Data as of Dec 18
| +0.24 / +10.34%|
The 1 analysts offering 12-month price forecasts for CytRx Corp have a median target of 12.00, with a high estimate of 12.00 and a low estimate of 12.00. The median estimate represents a +368.75% increase from the last price of 2.56.
The current consensus among 1 polled investment analysts is to Buy stock in CytRx Corp. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.